Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: A systematic literature review [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
BMC Medical Ethics 12 (1):6- (2011)
Background: An effectiveness assessment on ASCT in locally advanced and metastatic breast cancer identified serious ethical issues associated with this intervention. Our objective was to systematically review these aspects by means of a literature analysis. Methods: We chose the reflexive Socratic approach as the review method using Hofmann's question list, conducted a comprehensive literature search in biomedical, psychological and ethics bibliographic databases and screened the resulting hits in a 2-step selection process. Relevant arguments were assembled from the included articles, and were assessed and assigned to the question list. Hofmann's questions were addressed by synthesizing these arguments. Results: Of the identified 879 documents 102 included arguments related to one or more questions from Hofmann's question list. The most important ethical issues were the implementation of ASCT in clinical practice on the basis of phase-II trials in the 1990s and the publication of falsified data in the first randomized controlled trials (Bezwoda fraud), which caused significant negative effects on recruiting patients for further clinical trials and the doctor-patient relationship. Recent meta-analyses report a marginal effect in prolonging disease-free survival, accompanied by severe harms, including death. ASCT in breast cancer remains a stigmatized technology. Reported health-related-quality-of-life data are often at high risk of bias in favor of the survivors. Furthermore little attention has been paid to those patients who were dying. Conclusions: The questions were addressed in different degrees of completeness. All arguments were assignable to the questions. The central ethical dimensions of ASCT could be discussed by reviewing the published literature
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Norman Daniels & James E. Sabin (1998). Last Chance Therapies and Managed Care Pluralism, Fair Procedures, and Legitimacy. Hastings Center Report 28 (2):27-42.
H. E. M. van Luijn (2006). The Evaluation of the Risks and Benefits of Phase II Cancer Clinical Trials by Institutional Review Board (IRB) Members: A Case Study. Journal of Medical Ethics 32 (3):170-176.
Citations of this work BETA
No citations found.
Similar books and articles
Bernard Lo & Lindsay Parham (2010). Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease. Journal of Law, Medicine and Ethics 38 (2):257-266.
Myriam Skrutkowska & Charles Weijer, Do Patients with Breast Cancer Participating in Clinical Trials Receive Better Nursing Care?
Megan Eide & Ann Milliken Pederson (2009). God, Disease, and Spiritual Dilemmas: Reading the Lives of Women with Breast Cancer. Zygon 44 (1):85-96.
Frances M. Alexakos, Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer.
Frances M. Alexakos (2003). Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer. Dissertation, Salve Regina University
Roy Gilbar & Ora Gilbar (2009). The Medical Decision-Making Process and the Family: The Case of Breast Cancer Patients and Their Husbands. Bioethics 23 (3):183-192.
Neema Sofaer & Daniel Strech (2011). The Need for Systematic Reviews of Reasons. Bioethics 26 (6):315-328.
Tamra Lysaght & Alastair V. Campbell (2013). Broadening the Scope of Debates Around Stem Cell Research. Bioethics 27 (5):251-256.
David Shaw (forthcoming). Hematopoietic Stem Cell Transplantation: Legal and Ethical Issues in the UK. In Jörg P. Halter Peter Bürkli (ed.), The Legal and Ethical Challenges of Present and Future Stem-Cell Transplantation. Schwabe Verlag.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine and Ethics 38 (2):267-276.
Anya Plutynski (2012). Ethical Issues in Cancer Screening and Prevention. Journal of Medicine and Philosophy 37 (3):310-323.
Erika Kleiderman, Denise Avard, Lee Black, Zuanel Diaz, Caroline Rousseau & Bartha Knoppers (2012). Recruiting Terminally Ill Patients Into Non-Therapeutic Oncology Studies: Views of Health Professionals. [REVIEW] BMC Medical Ethics 13 (1):33-.
Ronald K. F. Fung & Ian H. Kerridge (2013). Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (Ips) Cells. Bioethics 27 (2):89-96.
Don Marquis (1989). An Ethical Problem Concerning Recent Therapeutic Research on Breast Cancer. Hypatia 4 (2):140 - 155.
Added to index2011-03-09
Total downloads11 ( #144,100 of 1,102,036 )
Recent downloads (6 months)3 ( #128,871 of 1,102,036 )
How can I increase my downloads?